Identification of the genes that are differentially expressed between radiosensitive and radioresistant cancers by global gene analysis may help to elucidate the mechanisms underlying tumor radioresistance and improve the efficacy of radiotherapy. An integrated analysis was conducted using publicly available GEO datasets to detect differentially expressed genes (DEGs) between cancer cells exhibiting radioresistance and cancer cells exhibiting radiosensitivity. Gene Ontology (GO) enrichment analyses, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis and protein-protein interaction (PPI) networks analysis were also performed. Five GEO datasets including 16 samples of radiosensitive cancers and radioresistant cancers were obtained. A total of 688 DEGs across these studies were identified, of which 374 were upregulated and 314 were downregulated in radioresistant cancer cell. The most significantly enriched GO terms were regulation of transcription, DNA-dependent (GO: 0006355, P = 7.00E-09) for biological processes, while those for molecular functions was protein binding (GO: 0005515, P = 1.01E-28), and those for cellular component was cytoplasm (GO: 0005737, P = 2.81E-26). The most significantly enriched pathway in our KEGG analysis was Pathways in cancer (P = 4.20E-07). PPI network analysis showed that IFIH1 (Degree = 33) was selected as the most significant hub protein. This integrated analysis may help to predict responses to radiotherapy and may also provide insights into the development of individualized therapies and novel therapeutic targets.
INTRODUCTION
Radiotherapy is a major modality of cancer therapy, but certain evidence reveals that radiotherapy (as monotherapy or in combination with other types of treatments) is effective in 52% of cancer patients, despite of more accurate tumor localization by computed tomography and better radiotherapy techniques. 1 The major reason for such low effectiveness of radiotherapy may be due to intrinsic tumor cell radioresistance. 2 Radioresistance of tumor cells is a multifactorial characteristic, mainly depending on the repair capacity of radiation-induced DNA lesions 3 and other factors including hypoxia, 4 differential gene expression, 5 growth factor receptors, mutations in proto-oncogenes and tumor suppressor genes, 6 expression of receptor tyrosine kinases 7 and adhesion of cells to extracellular matrix molecules. 8 Although such discoveries have significantly advanced the understanding of molecular mechanisms responsible for radiosensitivity of tumor cells which are essential for developing the personalized therapy and improving the patient prognosis, the entire process remains to be uncovered. Hence, it is urgently needed to discover new insights into the radioresistance mechanisms.
As a high-throughput technology, microarray analysis allows the simultaneous analysis of thousands of genes at the transcript expression level in a single experiment. The microarray have been widely used to detect the gene expression difference between radiosensitive and radioresistant tumors 9 to assess genes involved in radioresistance in a number of cancer cell types, including cervical, pancreatic, oral, lung, esophageal, head and neck cancers. [10] [11] [12] [13] Kim et al.
14 performed an integration of four radiosensitivity profiling data applied to NCI-60, of which the selected datasets and analytic methods were totally different from that of our study. The objective of this study was to identify common genes associated with radioresistance and relevant biological processes by systematic integration of gene expression data from different microarray platforms which is capable of increasing the statistical power to understand the mechanism of cancer cell radioresistance.
MATERIALS AND METHODS

Identification of eligible radioresistance gene expression datasets
Radioresistance expression profiling studies were identified by searching the Gene Expression Omnibus database (GEO, http://www.ncbi.nlm.nih. gov/geo). 15 The following key words and their combinations were used: 'radioresistance, cancer, gene expression, microarray'. Those datasets were obtained from original experimental articles, which make a comparison between radiosensitive and radioresistant cancer cells on the gene expression profiling. Non-human studies, review articles and integrated analysis of expression profiles were excluded.
Data preprocessing
Normalization is important for an accurate comparison of microarray datasets from multiple platforms. The heterogeneity of different microarray datasets is caused by different platforms, different gene nomenclature and different cancer type, so it is difficult to compare the microarray datasets directly. Inappropriate normalization may lead to skewing comparison results, and would reduce the credibility of measurements of changes in the expression of individual genes. In this study, the expression values for each gene were transformed to the z-score for global normalization. We investigated the global shifts of gene expression between radiosensitive and radioresistant cancer cell by using the assembled expression compendium. Z-scores were calculated for each probe as following: 
Statistical analysis
The Significance Analysis of Microarray software was then used to identify differentially expressed genes (DEGs) between radiosensitive and radioresistant cancer cell by carrying out gene-specific t-tests, with a 'relative difference' score for each gene. The definition of D value was the average gene expression change from different expression levels to the standard deviation of measurements for that gene. Genes with a fold-change 41.5 and false discovery rate ⩽ 0.05 were considered as DEGs. 16 The heat map of the top 50 DEGs was constructed by R statistical software.
Functional classification of DEGs
The biological functions of the DEGs were interpreted by Gene Ontology (GO) enrichment analysis using the web-based software GENECODIS. 17 GO provides a common descriptive framework and functional annotation and classification for analyzing gene sets. GO categories are organized into three groups: biological process, cellular component and molecular function. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database is a recognized and comprehensive database including all kinds of biochemistry pathways. 18 In this work, the KEGG database was applied to investigate the enrichment analysis of the DEGs to find the biochemistry pathways which might be involved in the tumor radioresistance.
PPI network construction
The protein-protein interactions (PPIs) research is of pivotal role to reveal the functions of proteins at the molecular level and discover the rules underlying cellular activities including growth, development, metabolism, differentiation and apoptosis. 19 The identification of protein interactions in a genome-wide scale is important to interpret the cellular control mechanisms. 20 In this study, we attempted to construct a PPI network based on Biological General Repository for Interaction Datasets (BioGRID) (http:// thebiogrid.org/) and the data in the constructed PPI network on the top 10 up-and downregulated DEGs were visualized with Cytoscape software (http://cytoscape.org/). 21 
RESULTS
Short overview of the studies included
A total of five expression profiling studies met inclusion criteria and were included. Across these studies, 16 samples of radiosensitive and radioresistant cancer cell was obtained. The general information of these studies is detailed in Table 1 . In these, studies on several types of cancer were included, such as head and neck cancer, nasopharyngeal carcinoma and lung cancer. DEGs associated with tumor radioresistance A total of 688 DEGs were found according to the cutoff criteria of fold-change 41.5 and false discovery rate ⩽ 0.05. Among those DEGs, 374 were upregulated and 314 genes were downregulated in radioresistant cancer cell. A list of the top 10 most significantly up-or downregulated genes is presented in Table 2 . The expression pattern of expression change for top 50 most significantly DEGs is displayed in Figure 1 . The upregulated gene with the lowest P-value was ARL6IP6, whose function is currently unknown. TNFRSF10A, a member of the TNF-receptor superfamily, which transduces cell death signal and induces cell apoptosis by activating tumor necrosis factorrelated apoptosis inducing ligand (TNFSF10/TRAIL), was the downregulated gene with the lowest P-value. The full list of these genes is provided in the Supplementary Table 1. Functional annotation of DEGs Genes with a nominal significance level of P o 0.01 were selected and tested against the background set of all genes with GO annotations. Regulation of transcription, DNA-dependent (GO: 0006355, P = 7.00E-09) and multicellular organismal development (GO: 0007275, P = 1.24E-08) were significantly enriched for biological processes (Figure 2a) . The other radioresistance-related functions that were enriched included cell adhesion, signal transduction, cell junction assembly and response to drug. While for molecular functions, protein binding (GO: 0005515, P = 1.01E-28) and metal ion binding (GO: 0046872, P = 2.15E-20) were significantly enriched, for cellular component, cytoplasm (GO: 0005737, P = 2.81E-26) and nucleus (GO: 0005634, P = 9.16E-22) were significantly enriched (Table 3) . Table 4 are pathways involving the identified DEGs that were statistically significant when a threshold P-value of less than 0.05 was used in the hypergeometric test. The most significant pathways in our KEGG analysis were pathways in cancer (P = 4.20E-07). In addition, focal adhesion (P = 1.59E-06) and cell adhesion molecules (CAMs) (P = 1.82E-06) are also highly enriched (Table 4, Figure 2b ).
Presented in
PPI network
The constructed PPI network consisted of 77 nodes and 76 edges. In PPI networks, degrees are defined to measure how many neighbors a node directly connect to, and the nodes with a high degree are defined as hub protein, and as illustrated in Figure 3 , the significant hub proteins contained IFIH1 (Degree = 33), GDA (Degree = 27) and TNFRSF10A (Degree = 25).
DISCUSSION
Radiotherapy is the primary treatment modality for cancer, but radioresistance on account of repeated treatments remains a serious obstacle to a satisfactory effect in many cases. To identify genes involved in radioresistance, we compared the expression profiles of 16 samples of radiosensitive and radioresistant cancer cell by integrating five microarray datasets. We also performed functional annotation including GO enrichment analysis, KEGG pathway analysis and PPI networks analysis to highlight the biological role for the DEGs.
A total of 688 genes were found to show altered expression in radiosensitive versus radioresistant cancer cell (374 upregulated and 314 downregulated). The upregulated gene with the lowest Figure 1 . Heat map visualization of the patterns of expression change for the top 50 most significantly DEGs across different datasets.
Radiotherapy-responsive gene networks in cancer D-L Hou et al P-value was ARL6IP6, whose function has been unknown. TNFRSF10A, which induces cell apoptosis upon binding to TRAIL, was the downregulated gene with the lowest P-value. TRAIL may be a promising candidate for cancer molecular-targeted agents because of its remarkable feature of selectively inducing apoptosis in tumors without causing toxicity to normal cells. In accordance with previous studies, a recent study detected epigenetic silence of TNFRSF10A in radioresistant laryngeal cancer, which lead to resistance to TRAIL-induced apoptosis. 22 This finding suggests an important role of TNFRSF10A in radioresistance, which may be meaningful for further targeted therapy for cancer. Common points have been noted between radioresistance and chemoresistance, which involves defects in apoptosis signaling or an increased ability to repair DNA. 23 Hence, we searched the reports of tumor radioresistance or chemoresistance referred to the top 10 most significantly up-or downregulated DEGs. In docetaxel-resistant castration-resistant prostate cancer cell lines, IFIH1 showed noteworthy down-expression by whole-genome 24 but there is no related reports about its role in tumor radioresistance. ABCB10 and other 12 members of ATP-binding cassette (ABC) including ABCA3, ABCB1 (MDR1), ABCB6, ABCB8, ABCB11, ABCC1 (MRP1), ABCC4, ABCC9, ABCD3, ABCD4, ABCE1 and ABCF2 transporter, were amplified among 19 of the 23 chemoresistant cell lines examined by subtractive comparative genomic hybridization. ABCC9 and ABCC1 were detected in our study. 25 Huang et al. 26 determined that SERPINB2, a known inhibitor of extracellular serine proteinase urokinasetype plasminogen activator, was significantly downregulated in cisplatin-resistant head and neck squamous cell carcinoma subclones compared with their isogenic drug-sensitive parental lines, suggesting its key role in chemoresistance in head and neck squamous cell carcinoma cell lines. Zhang et al. 27 found that GDA, which was downregulated by DNA methylation, induced cisplatin resistance in non-small cell lung cancer by high-throughput microarrays. Moreover, the important role of IFIH1, GDA and TNFRSF10A in radioresistance could be identified in the PPI analysis.
GO categories enrichment analysis was performed to understand the biological function of the DEGs. For biological processes, the significantly enriched GO term was transcription, DNAdependent, while that for molecular functions was protein binding, and for cellular component was cytoplasm. Some of the enriched GO terms may be radioresistance-related including cell adhesion, signal transduction, cell junction assembly and response to drug. KEGG pathway enrichment analysis was performed to further evaluate the pathways involved in tumor radioresistance. Pathways in cancer, focal adhesion and cell adhesion molecules (CAMs) are found to be highly enriched. Many DEGs were involved in pathways in cancer, including FGF5, IL6, RARB, ITGA6, COL4A6, FZD6 and so on, functioning in proliferation and anti-apoptosis. Cellular adhesion involved in radioresistance is proposed to produce anti-apoptotic signals when integrin-mediated adhesion interacts with the extracellular matrix. 28 One integrative metaanalysis of four microarray datasets between definitely radiosensitive and radioresistant NCI-60 cancer cells also determined the important role of cellular adhesion in tumor radioresistance. 14 The present study has two limitations. First, heterogeneity arising from various cancer types may have distorted the analysis. We combined five microarray datasets on response to radiotherapy of cancer cell lines to identify common radioresistant genes regardless of cancer type. Defining common radioresistant mechanisms not affected by cancer type is meaningful, but the actual cellular response in biological validation might differ among cancer types. Second, although we conducted global normalization for different data sets, the heterogeneity from different microarray platforms in each study cannot be removed.
CONCLUSIONS
In conclusion, this integrative analysis of five microarray datasets on response to radiotherapy of cancer cell lines showed the underlying molecular differences between radiosensitive and Figure 3 . The constructed protein-protein interaction networks of the top 10 up-and downregulated DEGs. Nodes represent proteins, edges represent interactions between two proteins. Red-and green-color nodes represent products of up-and downregulated DEGs, respectively. Blue nodes denote products of genes predicted to interact with the DEGs. radioresistant cancer cells, and identified DEGs and biological function to develop effective targeted therapies and understand common radioresistance mechanisms. Further functional studies may provide additional insights into the role of the differentially regulated genes in the tumor radioresistance.
